Daniela Catarzi - Concepedia

Author

Daniela Catarzi

University of Florence ORCID

Also Known As

CATARZI, DANIELA, Catarzi, Daniela, D CATARZI, D Catarzi, D. CATARZI, D. Catarzi, Daniela Catarzi

151

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Florence University of Ferrara Università di Camerino University of Padua University of Pisa

About

Daniela Catarzi is an author at University of Florence specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	44	1.3K
2	Biochemistry	24	41	1.3K
3	Natural Sciences	17	20	723
4	Engineering	1	1	19
5	Social Sciences	1	1	22

Daniela Catarzi

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Synthesis and Biological Evaluation of a New Set of Pyrazolo[1,5-<i>c</i>]quinazoline-2-carboxylates as Novel Excitatory Amino Acid Antagonists Flavia Varano, Daniela Catarzi, Vittoria Colotta, Journal of Medicinal Chemistry	2002	80
1,2,4-Triazolo[4,3-<i>a</i>]quinoxalin-1-one Moiety as an Attractive Scaffold To Develop New Potent and Selective Human A<sub>3</sub> Adenosine Receptor Antagonists: Synthesis, Pharmacological, and Ligand−Receptor Modeling Studies Vittoria Colotta, Daniela Catarzi, Flavia Varano, Journal of Medicinal Chemistry Adenosine ReceptorsAttractive ScaffoldReceptor AntagonistsAdenosine Receptor AntagonistsPharmacotherapy	2004	67
Synthesis and Structure−Activity Relationships of a New Set of 2-Arylpyrazolo[3,4-<i>c</i>]quinoline Derivatives as Adenosine Receptor Antagonists Vittoria Colotta, Daniela Catarzi, Flavia Varano, Journal of Medicinal Chemistry Adenosine ReceptorsAdenosine Receptor AntagonistsOrganic ChemistryPharmacotherapyHeterocycle Chemistry	2000	65
1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: Synthesis, biological evaluation, and molecular modeling study Flavia Varano, Daniela Catarzi, Vittoria Colotta, Bioorganic & Medicinal Chemistry Molecular PharmacologyMolecular Modeling StudyBiochemistryMedicineRational Drug Design	2005	65
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 Stefania Gessi, Serena Bencivenni, Enrica Battistello, Frontiers in Pharmacology	2017	64
The Identification of the 2-Phenylphthalazin-1(2<i>H</i>)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A<sub>3</sub>Adenosine Receptor Antagonists Daniela Poli, Daniela Catarzi, Vittoria Colotta, Journal of Medicinal Chemistry	2011	62
1,2,4-Triazolo[4,3-<i>a</i>]quinoxalin-1-one: A Versatile Tool for the Synthesis of Potent and Selective Adenosine Receptor Antagonists Vittoria Colotta, Daniela Catarzi, Flavia Varano, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistrySelective AntagonistHeterocyclicAdenosine Receptors	2000	61
New 2-Arylpyrazolo[3,4-<i>c</i>]quinoline Derivatives as Potent and Selective Human A<sub>3</sub>Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies Vittoria Colotta, Daniela Catarzi, Flavia Varano, Journal of Medicinal Chemistry	2007	58
4-Amido-2-aryl-1,2,4-triazolo[4,3-<i>a</i>]quinoxalin-1-ones as New Potent and Selective Human A<sub>3</sub>Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies Ombretta Lenzi, Vittoria Colotta, Daniela Catarzi, Journal of Medicinal Chemistry	2006	56
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-<i>d</i>]pyrimidine-5,7-diamine Derivatives: New Highly Potent A<sub>2A</sub>Adenosine Receptor Inverse Agonists with Antinociceptive Activity Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, Journal of Medicinal Chemistry	2016	56

Page 1